The Nicotine Addiction Label: Dr. Ardis on Congress, the FDA and 1994

Nearly every adult in the United States has read some version of the sentence “This product contains nicotine,” followed by the word “addictive.” Dr. Bryan Ardis, a chiropractor and podcaster, places the origin of that idea in one year: 1994. In April of that year, he says, the chief executives of the seven largest US tobacco companies swore under oath before Congress that nicotine is not addictive; in August the FDA declared that it is, and that every tobacco product would carry a warning. In his view the label taught a whole country to fear nicotine itself, when the addictive quality of tobacco products lies elsewhere — in the added flavour chemicals called pyrazines.

This page sets out his account in his order, then documents the public record of that period: the April 1994 congressional hearing, FDA Commissioner David Kessler’s letter and testimony, the August 1994 advisory committee, the 1995 and 1996 FDA rules and the Supreme Court case that overturned them, the 1988 Surgeon General’s report, the internal industry documents released in the 1990s, and the exact warning wording that federal rules require today.

Table of Contents

  1. What Dr. Ardis Says
  2. The April 1994 Hearing
  3. Commissioner Kessler’s 1994 Letter and Testimony
  4. August 1994: The FDA Advisory Committee
  5. The 1995–1996 FDA Rules and the Supreme Court
  6. Before 1994: The 1988 Surgeon General’s Report
  7. The Industry Documents
  8. The Warning Wording Required Today
  9. The 2016 Pyrazines Paper and the Vegetable Question
  10. Safety Notes
  11. Dr. Ardis’s Own Work
  12. Key Research Papers
  13. Connections
  14. Featured Videos

1. What Dr. Ardis Says

Dr. Ardis set this out in a 2025 podcast appearance (Culture Apothecary) and in his book Moving Beyond the COVID-19 Lies: Restoring Health and Hope for Humanity. His argument runs in five steps.

We were programmed to believe one thing about nicotine

Dr. Ardis states that Americans “have been programmed literally to believe that nicotine is nothing but a drug that is very addictive and only found in tobacco plants and tobacco products,” and that it causes cancer or ill health. He calls this a fraudulent idea, and says the information that would correct it “has been withheld from all of us for millennia.” He points to the label as the vehicle: anything containing tobacco, he says, must carry a warning that reads “This product contains nicotine, an addictive substance,” which he describes as the wording required by the FDA.

April 1994: seven chief executives under oath

Dr. Ardis states that in April 1994 the United States Congress invited the seven chief executives of the biggest tobacco companies in America to line up, state their names and employers, and swear under oath. Under threat of perjury, he says, “the senator” asked each of them whether nicotine is addictive, and all seven said nicotine is not addictive, one after another down the line.

August 1994: the FDA says it knows better

Four months later, he says, “the FDA said we know better than they do”: nicotine is addictive, highly addictive, that is what makes tobacco products dangerous, and a warning label would now go on every tobacco product made from then on. He describes this as the year “the FDA decided to lie to you about nicotine being addictive,” and says the media were “told and controlled by Big Pharma” to make sure the public did not learn certain things about nicotine.

2016: the Harvard paper, 22 years later

Dr. Ardis states that in 2016, “exactly 22 years later,” Harvard researchers published a study after evaluating about 7,000,000 pages that came from the FDA — research-and-development papers of tobacco companies going back to the 1970s — to ask whether it is truly nicotine that makes tobacco products addictive. In his reading the answer was no: the addictive, “learning” behaviour comes from pyrazines, which he says the FDA has allowed in tobacco products since 1970. “There’s one nutrient called nicotine in tobacco products,” he says; there are “15 man-made addictive chemicals called pyrazines in every single one of them.” The motive, he says, was to get people hooked and sell more product, “not unlike” sugar added to processed foods: “add it to anything, it makes it addictive.” That paper has its own page on this site: Pyrazines and Nicotine.

Who benefits

Dr. Ardis then asks why the FDA would require a label naming nicotine in 1994 when, as he puts it, it had for decades allowed 15 chemicals that are not nicotine to make tobacco products addictive. His answer is “Big Pharma.” Everyone in America, he says, has been programmed from birth to trust drugs only if they are FDA approved, and the FDA’s approval is what a product needs to win society’s approval.

His short answer to a doubtful doctor

Asked what he would say to a medical doctor who believes nicotine is addictive, Dr. Ardis gives a three-part reply. First: have you read the 2016 Harvard study saying nicotine is not responsible for the addictive quality of tobacco products — “do you think you know more than Harvard?” Second: have you ever eaten an eggplant or a tomato? Third: at a church or corporate function with celery and cauliflower vegetable trays, did you eat any, and did you wake up with night sweats, or ask your boss the next day for “a cauliflower break or for a tomato break”? The food, he says, “was loaded with nicotine,” and he asks why, if nicotine is as dangerous as claimed, doctors keep feeding children potato chips “made with nicotine.” The measured nicotine content of nightshade vegetables is set out on Nicotine in Nightshade Vegetables and Parkinson’s Disease.

The sections below document the records behind each date he names.

Back to Table of Contents

2. The April 1994 Hearing

On 14 April 1994 the Subcommittee on Health and the Environment of the US House of Representatives’ Committee on Energy and Commerce, chaired by Representative Henry Waxman of California, held a hearing on the regulation of tobacco products. The witnesses included the chief executives of the seven largest US tobacco companies, who were sworn in together and testified side by side.

The moment Dr. Ardis describes came when Representative Ron Wyden of Oregon, then a member of the House (he joined the Senate in 1996), asked each executive in turn whether he believed nicotine is addictive. Each answered that he did not believe nicotine is addictive. The photograph of the seven men standing with raised right hands became one of the best-known images of tobacco policy. The hearing was a House proceeding, so the questioner was a Representative rather than a senator.

The hearing was one of a series the subcommittee held that spring; Commissioner Kessler of the FDA testified before the same subcommittee in March and June 1994 (section 3). The executives’ testimony was later referred to the Justice Department, and the documents released over the following years (section 7) were set against it in the scientific literature.

Back to Table of Contents

3. Commissioner Kessler’s 1994 Letter and Testimony

The FDA’s move toward nicotine began before the hearing. On 25 February 1994 FDA Commissioner David Kessler wrote to the Coalition on Smoking OR Health, a group of health charities that had petitioned the agency. His letter said that evidence was accumulating that cigarette manufacturers might intend their products to contain nicotine to satisfy an addiction in some of their customers, and that if this were shown, the agency could regard cigarettes as drugs under the Federal Food, Drug, and Cosmetic Act. Under that law, a product’s legal status turns partly on the maker’s intended use, which is why “intent” sat at the centre of the FDA’s case.

Kessler testified to the Waxman subcommittee on 25 March 1994 and again on 21 June 1994. The June testimony concerned how nicotine levels in cigarettes could be controlled and adjusted during manufacture, including through tobacco blending and plant breeding. He published an account of the same subject that December in the journal Tobacco Control under the title “The control and manipulation of nicotine in cigarettes.” In 1995 he set out the agency’s reasoning on adolescents in the New England Journal of Medicine (“Nicotine addiction in young people”).

Back to Table of Contents

4. August 1994: The FDA Advisory Committee

The August 1994 event Dr. Ardis describes matches a meeting of the FDA’s Drug Abuse Advisory Committee, an outside panel of scientists. After a daylong hearing on 2 August 1994, the committee voted that nicotine is the agent in tobacco that leads people to become dependent, and that the nicotine levels in cigarettes then on the market were enough to cause addiction. Commissioner Kessler told reporters that the vote “changes the way we have to look at the whole issue of tobacco.”

The committee’s vote was a scientific finding for the agency’s record, not a labelling rule. The FDA did not issue a nicotine-addiction warning for tobacco packages in 1994; the steps that followed are set out in sections 5 and 8.

Back to Table of Contents

5. The 1995–1996 FDA Rules and the Supreme Court

On 11 August 1995 the FDA published a proposed rule asserting jurisdiction over cigarettes and smokeless tobacco as “drug delivery devices” for nicotine, aimed mainly at sales and advertising to minors. It drew more than 700,000 public comments. The final rule followed on 28 August 1996 (61 Federal Register 44396). It set 18 as the minimum age of sale with photo-identification checks, restricted vending machines and self-service displays, and limited advertising that reaches young people. Commissioner Kessler and colleagues described the rule and its findings in the New England Journal of Medicine in September 1996.

Tobacco manufacturers, retailers and advertisers challenged the rule. On 21 March 2000 the US Supreme Court decided FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120, by five votes to four. Justice Sandra Day O’Connor wrote for the majority that “Congress has directly spoken to the issue here and precluded the FDA’s jurisdiction to regulate tobacco products.” The ruling turned on the agency’s legal authority, not on the science: the same opinion said the agency had “amply demonstrated that tobacco use, particularly among children and adolescents, poses perhaps the single most significant threat to public health in the United States.” Justice Stephen Breyer wrote for the four dissenters.

Congress then gave the FDA that authority directly in the Family Smoking Prevention and Tobacco Control Act, signed on 22 June 2009 (Public Law 111-31), which created the agency’s Center for Tobacco Products. The center’s first director and the FDA’s leadership described the new law’s public-health standard in the New England Journal of Medicine in 2010.

Back to Table of Contents

6. Before 1994: The 1988 Surgeon General’s Report

The government’s formal statement that nicotine is addictive predates 1994 by six years. In May 1988 Surgeon General C. Everett Koop released The Health Consequences of Smoking: Nicotine Addiction, a report of more than 600 pages. Its three main conclusions were that cigarettes and other forms of tobacco are addicting; that nicotine is the drug in tobacco that causes addiction; and that the pharmacologic and behavioural processes that determine tobacco addiction are similar to those that determine addiction to drugs such as heroin and cocaine.

The report drew on laboratory work from the 1970s and 1980s, much of it at the Addiction Research Center of the National Institute on Drug Abuse. A 2024 paper by early presidents of the Society for Research on Nicotine and Tobacco describes how that society grew out of the 1988 report and was founded in 1994. Henningfield and Zeller (2006) trace the line from that psychopharmacology research to the FDA’s 1996 rule and later regulation.

Back to Table of Contents

7. The Industry Documents

Dr. Ardis’s figure of millions of pages of company research has a documented background. Three releases in the 1990s made internal tobacco-company papers public.

Henningfield, Rose and Zeller (2006) reviewed how the industry argued the addiction question in later litigation. They report that its expert witnesses compared tobacco to caffeine, chocolate and milk rather than to heroin or cocaine, and argued that the definition of addiction had broadened to include “carrots and caffeine” — an argument over where the line of “addictive” sits that runs parallel to Dr. Ardis’s vegetable-tray question.

Back to Table of Contents

8. The Warning Wording Required Today

The wording Dr. Ardis quotes is close to a federal requirement that exists today, and its history runs as follows.

  1. 1984. The Comprehensive Smoking Education Act set four rotating Surgeon General’s warnings for cigarette packs, on lung cancer, heart disease, emphysema, pregnancy and carbon monoxide. None of the four uses the word “addictive.”
  2. 2009. The Family Smoking Prevention and Tobacco Control Act wrote new warnings into law. One of the four required for smokeless tobacco reads “WARNING: Smokeless tobacco is addictive.” One of the nine statements the Act listed for cigarettes reads “WARNING: Cigarettes are addictive.”
  3. 2016–2018. On 10 May 2016 the FDA published the “deeming rule,” which extended its authority to e-cigarettes, cigars, pipe tobacco, hookah tobacco and other products. From 10 August 2018 the packages and advertisements of cigarette tobacco, roll-your-own tobacco and the newly covered products (cigars choose among six warnings) must carry: “WARNING: This product contains nicotine. Nicotine is an addictive chemical.” Products that contain no nicotine are not subject to it. The FDA’s retailer chart of required warning statements gives the exact text.

Laestadius and colleagues (2020) studied how often that statement appeared on promotional social-media posts for e-liquids before and after 10 August 2018. Before the date none of the posts they sampled carried it; afterwards 13.6% of all posts, and 36.4% of US-based posts, used the FDA-compliant wording.

Back to Table of Contents

9. The 2016 Pyrazines Paper and the Vegetable Question

The study Dr. Ardis calls the 2016 Harvard paper is Alpert, Agaku and Connolly, “A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction,” Tobacco Control (published online in 2015; print issue July 2016). The authors were at the Harvard T.H. Chan School of Public Health. They searched internal industry documents and the additive lists manufacturers had given to US health agencies, including the 1994 list. The paper is laid out section by section, with its Box 1 list of pyrazines, on Pyrazines and Nicotine. Three companion pages cover what pyrazines are, how they entered ‘light’ cigarettes and craving cues, dopamine and e-cigarettes.

For background on nicotine itself, Benowitz’s 2010 review in the New England Journal of Medicine describes how nicotine binds receptors in the brain, triggers the release of dopamine and other signalling chemicals, and how withdrawal and learned associations with the sights, smells and rituals of smoking (“cues”) keep people smoking. The receptors involved are explained on Nicotinic Acetylcholine Receptors.

Dr. Ardis’s vegetable question rests on the finding that tomatoes, eggplant, potatoes and peppers — the nightshade family — contain small, measurable amounts of nicotine. The published measurements, and how they compare with tobacco, are documented on Nicotine in Nightshade Vegetables and Parkinson’s Disease. The best-known measurements are a 1993 letter in the New England Journal of Medicine by Domino, Hornbach and Demana, “The nicotine content of common vegetables.”

Back to Table of Contents

10. Safety Notes

Back to Table of Contents

Dr. Ardis’s Own Work

Back to Table of Contents

Key Research Papers

  1. Kessler DA (1994). The control and manipulation of nicotine in cigarettes. Tobacco Control 3:362–369. — doi:10.1136/tc.3.4.362
  2. Domino EF, Hornbach E, Demana T (1993). The nicotine content of common vegetables. N Engl J Med 329:437. — PubMed PMID: 8326992
  3. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J (1995). Looking through a keyhole at the tobacco industry. The Brown and Williamson documents. JAMA 274:219–224. — PubMed PMID: 7609230
  4. Slade J, Bero LA, Hanauer P, Barnes DE, Glantz SA (1995). Nicotine and addiction. The Brown and Williamson documents. JAMA 274:225–233. — PubMed PMID: 7609231
  5. Kessler DA (1995). Nicotine addiction in young people. N Engl J Med 333:186–189. — PubMed PMID: 7791824
  6. Kessler DA, Witt AM, Barnett PS, Zeller MR, Natanblut SL, Wilkenfeld JP, Lorraine CC, Thompson LJ, Schultz WB (1996). The Food and Drug Administration’s regulation of tobacco products. N Engl J Med 335:988–994. — PubMed PMID: 8782508
  7. Hurt RD, Robertson CR (1998). Prying open the door to the tobacco industry’s secrets about nicotine: the Minnesota Tobacco Trial. JAMA 280:1173–1181. — PubMed PMID: 9777818
  8. Henningfield JE, Zeller M (2006). Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward. Psychopharmacology (Berl) 184:286–291. — PubMed PMID: 16463054
  9. Henningfield JE, Rose CA, Zeller M (2006). Tobacco industry litigation position on addiction: continued dependence on past views. Tob Control 15 Suppl 4:iv27–iv36. — PubMed PMID: 17130621
  10. Benowitz NL (2010). Nicotine addiction. N Engl J Med 362:2295–2303. — PubMed PMID: 20554984
  11. Deyton L, Sharfstein J, Hamburg M (2010). Tobacco product regulation — a public health approach. N Engl J Med 362:1753–1756. — PubMed PMID: 20410498
  12. Alpert HR, Agaku IT, Connolly GN (2016). A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction. Tob Control 25:444–450. — PubMed PMID: 26063608
  13. Laestadius LI, Wahl MM, Vassey J, Cho YI (2020). Compliance with FDA nicotine warning statement provisions in e-liquid promotion posts on Instagram. Nicotine Tob Res 22:1823–1830. — PubMed PMID: 32433737
  14. Pomerleau OF, Benowitz NL, Stitzer ML, Henningfield JE, Hatsukami DK, Corrigall WA, Perkins KA, Lando HA (2024). Society for Research on Nicotine and Tobacco as an outgrowth of the 1988 Surgeon General’s report on nicotine addiction: reflections of the early presidents. Nicotine Tob Res 26:118–125. — PubMed PMID: 37584666

PubMed Topic Searches

  1. PubMed: Tobacco industry documents and nicotine addiction
  2. PubMed: History of FDA tobacco regulation
  3. PubMed: Nicotine warning statements

Government Records and Court Opinions

Back to Table of Contents

Connections

Back to Table of Contents